Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | FASN | P49327 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | F7 | P08709 | 1/20 | 0.34 |
| ▸ | F3 | P13726 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4395866 | 1.00 | TSHR (0.46) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL4074574 | 0.84 | — | — | |
| SCHEMBL387383 | 0.84 | — | — | |
| SCHEMBL2274578 | 0.84 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL26905336 | 0.84 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL2274584 | 0.84 | TSHR (0.59) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL1180790 | 0.82 | TSHR (0.48) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL875892 | 0.82 | TSHR (0.48) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL2273586 | 0.78 | TSHR (0.54) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL2571772 | 0.78 | TSHR (0.68) | TSHRALDH1A1FASNFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11999674-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-04 | — | — | US | claimed |
| US-20230331643-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-19 | — | — | US | claimed |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-01 | — | — | US | claimed |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-07-07 | — | — | US | claimed |
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-26 | — | — | US | claimed |
| CN-107438630-B | Butadiene short-chain polymerization catalyst and preparation thereof | 陶氏环球技术有限责任公司 | 2020-09-15 | — | — | CN | claimed |
| EP-3280690-B1 | BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-19 | — | — | EP | claimed |
| US-20180072637-A1 | BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-15 | — | — | US | claimed |
| EP-3280690-A1 | BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF | Dow Global Technologies LLC (US) | 2018-02-14 | — | — | EP | claimed |
| EP-3080136-A2 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | Dow Global Technologies Llc (US) | 2016-10-19 | — | — | EP | claimed |
| WO-2016164258-A1 | BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-10-13 | — | — | WO | claimed |
| US-20160271601-A1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | DOW OLEFINVERBUND GMBH (DE) | 2016-09-22 | — | — | US | claimed |
| WO-2015088867-A2 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-18 | — | — | WO | claimed |
| US-5004568-A | Reacting With Carbon Monoxide Using A Group 8 Noble Metal Halide Catalyst And A Group 1B Metal Halide | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1991-04-02 | — | — | US | claimed |
| US-4767574-A | CATALYTIC WITH GROUP 8 NOBLE METAL HALIDE AND HALIDE COMPOUND | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1988-08-30 | — | — | US | claimed |
| US-4642392-A | Conjugated alkadiene telomerization to organo-oxyalkadienes | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1987-02-10 | — | — | US | claimed |
| US-4622416-A | GROUP 8 HALIDE CATALYSTS | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1986-11-11 | — | — | US | claimed |
| US-4078005-A | BROMINATION | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DT) | 1978-03-07 | — | — | US | claimed |
| US-11999674-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-04 | — | — | US | disclosed |
| US-4078005-A | BROMINATION | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DT) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | TELO2, TERT, POT1 | TSHR 1679/4885ALDH1A1 824/4885FASN 4041/4885 |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885FASN 3788/4885 |
| US-20180072637-A1 | BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF | TELO2, TERT, POT1 | TSHR 1679/4885ALDH1A1 824/4885FASN 4041/4885 |
| US-20230331643-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885FASN 3788/4885 |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885FASN 3788/4885 |
| US-11999674-B2 | Butadiene telomerization catalyst preparation and use thereof | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885FASN 3788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.